In Brief: Parsol 1789
This article was originally published in The Rose Sheet
Executive Summary
Parsol 1789: FDA tentatively schedules "OTC feedback" meeting with Schering-Plough and Givaudan Roure on Aug. 11 to discuss the UVA/UVB-blocking sunscreen ingredient. Parsol 1789 also was the subject of an "OTC feedback" meeting in March ("The Rose Sheet" March 13, p. 8). Another "OTC feedback" meeting with FDA is set for July 24 to discuss tea tree oil. Representatives of the American Tea Tree Association and the Australian Tea Tree Association will meet with the agency...